(Total Views: 487)
Posted On: 02/01/2022 1:50:21 PM
Post# of 157664
Agree merge seems less likely than a partnership but I’m drawing parallels with smaller companies. GILD originally wanted to merge with IMMU.
Maybe I’m a little far off and buyout would be higher on the drawing board than merge but I just think a buyout is not happening.
Maybe someone can debunk what I’m saying or add to why a merge would make more sense than just a partnership. I just found it odd GILD was looking to merge originally with IMMU before a buyout.
Maybe I’m a little far off and buyout would be higher on the drawing board than merge but I just think a buyout is not happening.
Maybe someone can debunk what I’m saying or add to why a merge would make more sense than just a partnership. I just found it odd GILD was looking to merge originally with IMMU before a buyout.


Federal Whistleblower
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)
Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech
https://img1.wsimg.com/blobby/go/05a949a0-169...5_FULL.pdf
Case References
• HHS & SEC Whistleblower: HL-1412396
• DOJ Investigation Report / Whistleblower ID: 20250705-0001
• NIH Case Reference: CS1137565
• DoD Case: 16282
• IC IG / 50 U.S.C. §3033 / ARPA-H (Advanced Research Projects Agency for Health)
Founder & CEO
FireGate BioTech | AI Lux Veritas™
Contact FireGate Biotech
https://img1.wsimg.com/blobby/go/05a949a0-169...5_FULL.pdf